Patents by Inventor Ryosuke Katsuyama

Ryosuke Katsuyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110300068
    Abstract: The present invention provides an agent for the prophylaxis or treatment of kidney cancer or urinary bladder cancer, and a diagnostic reagent for these cancers which comprise an antibody against nerve growth factor 2/neurotrophin-3 or a partial peptide thereof or a salt thereof, which antibody neutralizes nerve growth factor 2/neurotrophin-3 and does not cross-react with the Nerve Growth Factor.
    Type: Application
    Filed: January 12, 2010
    Publication date: December 8, 2011
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Tatsuya Watanabe, Shinichi Kondo, Ryosuke Katsuyama
  • Publication number: 20100086911
    Abstract: Identification of a novel target molecule for preventing/treating cancer and a preventive/remedy agent for cancer which targets the molecule, specifically, an agent for promoting the apoptosis in cancer cells and/or inhibiting the growth of cancer cells and a preventive/remedy agent for cancer, which comprise an antibody against a protein including the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, or SEQ ID NO: 10; an antisense polynucleotide of the protein (preferably, siRNA against mRNA of the protein); and a substance controlling the expression and/or activity of the protein, are provided by the present invention.
    Type: Application
    Filed: March 2, 2006
    Publication date: April 8, 2010
    Inventors: Ryosuke Katsuyama, Shinichi Kondo
  • Publication number: 20050106152
    Abstract: A compound or its salt that regulates the activities of a protein having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, an antisense nucleotide containing a base sequence or a part thereof which is complementary or substantially complementary io the base sequence of a DNA encoding a protein or its partial peptide having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, etc. can be used as preventive/therapeutic agents for cancer, etc.
    Type: Application
    Filed: December 26, 2002
    Publication date: May 19, 2005
    Inventors: Yuichi Hikichi, Ryosuke Katsuyama, Yuichi Kakoi